Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment
about
Treating nausea and vomiting in palliative care: a reviewGastroparesis: concepts, controversies, and challengesTreatment of refractory diabetic gastroparesis: Western medicine and traditional Chinese medicine therapiesStomach dysfunction in diabetes mellitus: emerging technology and pharmacologyRapid improvement in post-infectious gastroparesis symptoms with mirtazapine.Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: evidence of disrupted noradrenergic signaling in anxiety-related alcohol use.Clinical guideline: management of gastroparesisReview of the use of mirtazapine in the treatment of depression.Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years.Emerging drugs for the treatment of gastroparesis.Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.Management of gastroparesis.Recent advances in the pathophysiology and treatment of gastroparesis.Mirtazapine treatment of diabetic gastroparesis as a novel method to reduce tube-feed residual: a case report.Gastroparesis in pregnancy: case report and literature reviewEvaluation and treatment of gastric stimulator failure in patients with gastroparesis.Sensory neuromodulators in functional nausea and vomiting: predictors of responseGastroparesis: pathogenesis, diagnosis and management.Pathogenesis, investigation and dietary and medical management of gastroparesis.Mirtazapine: a solution for postoperative gastroparesis?Diabetic gastroparesis: recent insights into pathophysiology and implications for management.Gastroparesis: from concepts to management.Current advances in treatment of gastroparesis.Emerging strategies for the treatment of gastroparesis.Mirtazapine for symptom control in refractory gastroparesis.Newest Drugs for Chronic Unexplained Nausea and Vomiting.Investigational drug therapies for the treatment of gastroparesis.Effect of Mirtazapine on Gastric Emptying in Patients with Cancer-associated Anorexia.The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial.The effect of mirtazapine on gastric accommodation, gastric sensitivity to distention, and nutrient tolerance in healthy subjects.A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research
P2860
Q24635649-EFD5A5F5-D42C-4907-81A0-2E5FBA391376Q26998965-31CA86FD-75C4-4F69-9DD2-7D7BF59B4104Q27014169-1AAE8476-9B60-41A5-94F4-D6356A2550ADQ33674557-6FBDDD58-9595-4F79-A2BE-272C48EE9EE8Q33718370-6E8E534E-AEF7-47A6-BF8E-B941E8AE0A74Q34025026-8442F00C-B9EC-4380-ACCE-CE709E46419AQ34034345-0686CCEC-4293-41D8-A060-4F37D58380F7Q34190102-A8307A99-2B91-4970-B9E1-3F70358E5F92Q34378282-441214D7-6482-4469-9F5D-E0E68DE33100Q34412103-6B041FEC-3966-43B7-88C4-D6AD9853F65AQ34588606-A2035CC1-DCFF-41E6-91BE-EF9602CE00F5Q34601693-749B5666-ED6A-4331-A299-370232C375E8Q36542667-8578C7E9-4E49-4EFD-85E3-6724B464C290Q36604072-394F8F0C-8559-4A1C-BF3F-F28131F352ACQ37186013-250A66E8-F4DB-486B-AA60-F8610DB5B4B7Q37384038-8BED6F26-86C3-47A1-848D-5735401BF712Q37642639-6EFD57E0-FDC7-42A1-9A45-A3DF81B418AFQ37902510-57906D20-452C-409A-B4BC-A446F47C2C3BQ37903393-3D87D99A-E7B6-4B81-9261-19C818951F4BQ37918813-468429E3-3232-4F0C-8A64-DF1926B7E2DDQ38077822-AD2AB7AD-7D4D-4CDC-8933-57575B5A7123Q38116759-15C338E1-48DC-4F20-8C56-B2E9B86B6EA5Q38550545-564C9CF7-43A9-4C41-8336-6BF37DFE4CB5Q38721476-9AA2A882-F535-4788-8967-4A26A7C4FDBAQ38837513-DC5B8441-CEBC-404E-A8AC-4AFE16D6CBC3Q38977503-0B9A7872-4096-4CE4-983C-D3FDBFE9148FQ39106195-3249F422-5921-4F69-87DF-98B71B38B48DQ41274026-CB9E0DD0-1F66-479C-A876-3BCE992C7F5CQ46887384-FF4F5831-5101-4F8B-8D9E-45FB808156A4Q48147155-37396FC9-E2F1-4CD6-95D8-938E941B6CC0Q57161235-975A801A-A361-4FDD-8707-35FDFECC7BFA
P2860
Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment
@ast
Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment
@en
Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment
@nl
type
label
Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment
@ast
Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment
@en
Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment
@nl
prefLabel
Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment
@ast
Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment
@en
Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment
@nl
P2093
P1433
P1476
Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment
@en
P2093
Ho-cheol Kang
Il-seon Shin
Jae-min Kim
Ji-ung Mun
Jin-sang Yoon
Su-jin Yang
Sung-wan Kim
P356
10.1176/APPI.PSY.47.5.440
P407
P577
2006-01-01T00:00:00Z